Negara: Amerika Serikat
Bahasa: Inggris
Sumber: NLM (National Library of Medicine)
FLURAZEPAM HYDROCHLORIDE (UNII: 756RDM536M) (FLURAZEPAM - UNII:IHP475989U)
West-ward Pharmaceutical Corp
FLURAZEPAM HYDROCHLORIDE
FLURAZEPAM HYDROCHLORIDE 15 mg
ORAL
PRESCRIPTION DRUG
Flurazepam Hydrochloride Capsules are a hypnotic agent useful for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakening. Flurazepam Hydrochloride Capsules can be used effectively in patients with recurring insomnia or poor sleeping habits, and in acute or chronic medical situations requiring restful sleep. Sleep laboratory studies have objectively determined that Flurazepam Hydrochloride Capsules are effective for at least 28 consecutive nights of drug administration. Since insomnia is often transient and intermittent short-term use is usually sufficient. Prolonged use of hypnotics is usually not indicated and should only be undertaken concomitantly with appropriate evaluation of the patient. Flurazepam Hydrochloride Capsules are contraindicated in patients with known hypersensitivity to the drug. Benzodiazepines may cause fetal damage when administered during pregnancy. An increased risk of congenital malformations associated wi
Flurazepam Hydrochloride Capsules, USP 15 mg: Blue/white, No. 2 hard gelatin capsule printed “West-ward Flurazepam 15”. Bottles of 30 capsules Bottles of 100 capsules Bottles of 500 capsules Flurazepam Hydrochloride Capsules, USP 30 mg: Blue/blue, No. 2 hard gelatin capsule printed “West-ward Flurazepam 30”. Bottles of 30 capsules Bottles of 100 capsules Bottles of 500 capsules Store at 20-25°C (68-77°F) [See USP Controlled Room Temperature]. Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
Abbreviated New Drug Application
FLURAZEPAM- FLURAZEPAM HYDROCHLORIDE CAPSULE West-ward Pharmaceutical Corp ---------- MEDICATION GUIDE Flurazepam (flew-raz-e-pam) HCl Capsules, 15 mg and 30 mg, are a Sedative-Hypnotic indicated for Insomnia CIV Rx Only Read this Medication Guide carefully before you start taking your medicine and each time you get more, since there may be new information. It does not contain all the information about your medicine that you may need to know, so please ask your doctor, nurse or pharmacist if you have any questions. IMPORTANT YOUR DOCTOR HAS PRESCRIBED THIS DRUG FOR YOUR USE ONLY. DO NOT LET ANYONE ELSE USE IT. KEEP THIS MEDICINE OUT OF THE REACH OF CHILDREN AND PETS. If a child puts a Flurazepam Hydrochloride Capsule in his or her mouth or swallows it, call your local Poison Control Center or go immediately to the nearest emergency room. What is the most important information I should know about sedative-hypnotic drugs? After taking a sedative-hypnotic drug, you may get up out of bed while not being fully awake and do an activity that you do not know you are doing. The next morning, you may not remember that you did anything during the night. You have a higher chance for doing these activities if you drink alcohol or take other medications that make you sleepy with a sedative-hypnotic drug. Reported activities include: • driving a car (“sleep-driving”) • making and eating food • talking on the phone • having sex • sleep-walking Important: 1. Take a sedative-hypnotic drug exactly as prescribed: • Do not take more sedative-hypnotic drugs than prescribed. • Take the sedative-hypnotic drug right before you get in bed, not sooner. 2. Do not take a sedative-hypnotic drug if you: • drink alcohol • take other medicines that can make you sleepy. Talk to your doctor about all of your medicines. Your doctor will tell you if you can take a sedative-hypnotic drug with your other medicines • cannot get a full night sleep 3. Call your doctor right away if you find out that you have done any of the above Baca dokumen lengkapnya
FLURAZEPAM- FLURAZEPAM HYDROCHLORIDE CAPSULE WEST-WARD PHARMACEUTICAL CORP ---------- FLURAZEPAM HYDROCHLORIDE CAPSULES, USP C RX ONLY Rev. 10/10 DESCRIPTION Flurazepam hydrochloride is chemically 7-chloro-1-[2(diethylamino)ethyl]-5-(_o_-fluorophenyl)-1,3- dihydro-2_H_-1,4-benzodiazepin-2-one dihydrochloride. It is a pale yellow, crystalline compound, freely soluble in alcohol and very soluble in water. It has a molecular weight of 460.81 and the following structural formula: Each capsule, for oral administration, contains 15 mg or 30 mg of flurazepam hydrochloride. In addition, each capsule contains the following inactive ingredients: lactose monohydrate, magnesium stearate, pregelatinized starch , and sodium starch glycolate. Capsules shells may contain: colloidal silicon dioxide, FD&C Blue No. 1, FD&C Red No. 3, gelatin, silicon dioxide, sodium lauryl sulfate, and titanium dioxide. CLINICAL PHARMACOLOGY Flurazepam hydrochloride is rapidly absorbed from the GI tract. Flurazepam is rapidly metabolized and is excreted primarily in the urine. Following a single oral dose, peak flurazepam plasma concentrations ranging from 0.5 to 4.0 ng/mL occur at 30 to 60 minutes post-dosing. The harmonic mean apparent half- life of flurazepam is 2.3 hours. The blood level profile of flurazepam and its major metabolites was determined in man following the oral administration of 30 mg daily for 2 weeks. The N -hydroxyethyl- flurazepam was measurable only during the early hours after a 30 mg dose and was not detectable after 24 hours. The major metabolite in blood was N -desalkyl-flurazepam which reached steady-state (plateau) levels after 7 to 10 days of dosing, at levels approximately five- to six-fold greater than the 24-hour levels observed on Day 1. The half-life of elimination of N -desalkyl-flurazepam ranged from 47 to 100 hours. The major urinary metabolite is conjugated N -hydroxyethyl-flurazepam which accounts for 22% to 55% of the dose. Less than 1% of the dose is excreted in the urine as N -desalkyl- IV 1 1 1 1 1 fluraz Baca dokumen lengkapnya